Lipid-based nanoparticles to address the limitations of GBM therapy by overcoming the blood-brain barrier, targeting glioblastoma stem cells, and counteracting the immunosuppressive tumor microenvironment
2024 · Biomedicine & Pharmacotherapy · 56 citations
https://doi.org/10.1016/j.biopha.2023.116113